Efficacy of Intranasal Probiotic Treatment to Reduce Severity of Symptoms in COVID19 Infection
Clinical trial NCT04458519 · COMPLETED
Trial details
- NCT number
- NCT04458519
- Sponsor
- Centre hospitalier de l'Université de Montréal (CHUM)
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-16
- Primary completion
- 2021-05-27
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.